Targeting GPP: A Guide for Dermatologists on Diagnosis, Burden, Management and Therapeutic Breakthroughs
This program is a 45-minute eCME course for Canadian HCPs focusing on the diagnosis and management of generalized pustular psoriasis, including a case study and discussion on spesolimab.
- The program examines the clinical presentation and impacts of generalized pustular psoriasis.
- It explores the role of the IL-36 receptor pathway in disease pathogenesis.
- Spesolimab, a Health Canada-approved treatment, is discussed.
- The program received financial support from Boehringer Ingelheim.
AI Readiness
Good foundation, but some important product data is still missing.
53%